SenguptaV, SenguptaS, Lazo JrA, WoodsP, NolanA and BremerN. (2020). Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev, 29:747–754.
2.
WitwerKW, Van BalkomBWM, BrunoS, ChooA, DominiciM, GimonaM, de KleijnD, KohM, LaiRC, et al. (2019). Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles, 8:1609206.
3.
ThéryC, WitwerKW, AikawaE, AlcarazMJ, AndersonJD, AndrianstsitohainaR, AntoniouA, ArabT, Archer et alF. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles, 7:1535750.
4.
BörgerV, WeissDJ, AndersonJD, BorràsFE, BussolattiB, CarterDRF, DominiciM, Falcón-PérezJM, GimonaM, et al. (2020). ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19. Cytotherapy [Epub ahead of print]; DOI: 10.1016/j.jcyt.2020.05.002.
